Cargando…
LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3
Over the past several years, long non‐coding RNAs (lncRNAs) have attracted more and more attention due to their special functions. They are vital biomarkers in multiple diseases. LncRNA HOMEOBOX A11 (HOXA11) has been found to be aberrantly expressed in some kinds of malignant tumors. In this study,...
Autores principales: | Zhao, Xia, Li, Xiaoyou, Zhou, Leilei, Ni, Jie, Yan, Wenyue, Ma, Rong, Wu, Jianzhong, Feng, Jifeng, Chen, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172072/ https://www.ncbi.nlm.nih.gov/pubmed/30099826 http://dx.doi.org/10.1111/cas.13764 |
Ejemplares similares
-
LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells
por: Lin, Shuang, et al.
Publicado: (2019) -
Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021) -
LncRNA PTCSC3 Alleviates the Postoperative Distant Recurrence of Gastric Cancer by Suppression of lncRNA HOXA11-AS
por: Xu, Jiapeng, et al.
Publicado: (2020) -
ARID1B/SUB1‐activated lncRNA HOXA‐AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3
por: Liu, Gongbao, et al.
Publicado: (2021) -
The integrated comprehension of lncRNA HOXA-AS3 implication on human diseases
por: Yao, Qinfan, et al.
Publicado: (2022)